What is Lushang Freda Pharmaceutical Co.,Ltd.'s (600223.SS) StockRank?

MoatMap's StockRank for Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS) is 33/100, with a Sell signal. This is a composite score combining Quality (69), Value (32), and Momentum (24) factor ranks across MoatMap's 20,000+ stock universe.

Does Lushang Freda Pharmaceutical Co.,Ltd. have an economic moat?

Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS) has a Quality factor score of 69/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Lushang Freda Pharmaceutical Co.,Ltd. a buy, hold, or sell?

MoatMap's current signal for Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS) is Sell, based on a StockRank of 33/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Lushang Freda Pharmaceutical Co.,Ltd. in?

Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS) operates in the Real Estate sector, specifically the Real Estate - Development industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

600223.SS

SELLREMOVE

Lushang Freda Pharmaceutical Co.,Ltd. · Real Estate · China · $909M · Avg Vol: $6M/d

StockRank

P/E (TTM)

35.3x

ROE

4.3%

D/E

0.0x

Dividend %

1.0%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Lushang Freda Pharmaceutical operates a mixed business model spanning real estate and cosmetics/pharmaceuticals. This lack of strategic focus and exposure to Chinese property headwinds disqualifies it.

COMPANY DESCRIPTION

Lushang Freda Pharmaceutical Co., Ltd. has transitioned from real estate development into a leading producer of hyaluronic acid-based cosmetics, pharmaceuticals, and health foods. The company leverages Freda's deep R&D heritage in biopharmaceuticals to maintain a strong competitive position in China's functional skincare market. It represents a unique corporate transformation, combining legacy real estate assets with high-growth biomedical operations.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	1.9B	677M	589M	540M	-34.4%
EPS	0.01	0.04	0.04	0.03	65.1%
Shares	1.0B	1.0B	1.0B	1.0B	0.0%
Debt	1.1B	322M	42M	20M	-73.9%
Equity	549M	593M	607M	626M	4.4%
Op CF	148M	70M	34M	41M	-34.8%
Inv CF	182,716	395M	442M	-9M	—
Fin CF	-239M	-458M	-311M	-37M	—

PRICE (1M)-22.7%

SMA 50SMA 200

$0.78

RSI (14)

24.8

52W High

$1.38

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

5.8%59.8

ROE

4.3%38.9

GP/Assets

33.8%95.4

Op. Margin

2.6%15.0

FCF/Assets

3.2%61.1

Piotroski

—88.4

Int. Cover

49.8x94.1

D/E Ratio

0.04x97.2

Current Ratio

4.61x91.2

Value

P/E (TTM)

35.3x15.8

EV/EBITDA

15.1x56.1

P/FCF

220.7x20.3

P/B

1.3x27.3

P/S

1.6x71.9

Div Yield

1.0%15.3

Momentum

52W High %

57%9.1

RS 6M

-38%21.9

SMA 50/200

0.87x10.5

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—69.0

Q Growth

-37%18.1

FUNDAMENTALS

Market Cap

$909M

P/E (Forward)

20.1x

Gross Margin

53.7%

SECTOR PEERS

Closest peers in Real Estate, ranked by industry match, size, and score similarity. Cross-listings of 600223.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
600223.SS	Lushang Freda Pharmaceutical Co.,Ltd.(you)	$909M	33	SELL
000517.SZ	Rongan Property Co.,Ltd.	$885M	31	SELL
3380.HK	Logan Group Company Limited	$930M	24	SELL
000402.SZ	Financial Street Holdings Co., Ltd.	$1.4B	32	SELL
002077.SZ	Jiangsu Dagang Co., Ltd.	$1.5B	34	SELL
601588.SS	Beijing North Star Company Limited	$1.0B	41	HOLD
600748.SS	Shanghai Industrial Development Co.,Ltd	$1.3B	28	SELL
2923.TW	Sino Horizon Holdings Limited	$1.4B	29	SELL
600708.SS	Bright Real Estate Group Co.,Limited	$1.1B	24	SELL
1030.HK	Seazen Group Limited	$1.7B	35	HOLD

Peer medians: ROE 0.4% · P/E 23.3x · Gross margin 17.3%

Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS) — Stock Score Summary

Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS) has a MoatMap StockRank of 33/100 based on Quality (69/100), Value (32/100), and Momentum (24/100) factor scores. The current signal is SELL. Lushang Freda Pharmaceutical operates a mixed business model spanning real estate and cosmetics/pharmaceuticals. This lack of strategic focus and exposure to Chinese property headwinds disqualifies it.

Key Financial Metrics

Price	$0.78
Market Cap	$909M
P/E (TTM)	35.25
P/E (Forward)	20.14
Price/Book	1.34
Return on Equity	4.3%
Return on Invested Capital	5.8%
Debt/Equity	3.53
Gross Margin	53.7%
Operating Margin	2.6%
Revenue Growth	2.8%
Dividend Yield	1.0%
Free Cash Flow	$4M

Lushang Freda Pharmaceutical Co.,Ltd. operates in the Real Estate - Development industry, part of the Real Estate sector (China).

Frequently Asked Questions

What is Lushang Freda Pharmaceutical Co.,Ltd.’s (600223.SS) StockRank?: MoatMap’s StockRank for Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS) is 33/100, with a Sell signal. It is a composite of Quality (69), Value (32), and Momentum (24) factor ranks across MoatMap’s 20,000+ stock universe.
Does Lushang Freda Pharmaceutical Co.,Ltd. have an economic moat?: Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS) has a Quality factor score of 69/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Lushang Freda Pharmaceutical Co.,Ltd. a buy, hold, or sell?: MoatMap’s current signal for Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS) is Sell, based on a StockRank of 33/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Lushang Freda Pharmaceutical Co.,Ltd. in?: Lushang Freda Pharmaceutical Co.,Ltd. (600223.SS) operates in the Real Estate sector, specifically the Real Estate - Development industry (China).